首页> 外文期刊>Acta biomaterialia >Cardiac extracellular matrix-fibrin hybrid scaffolds with tunable properties for cardiovascular tissue engineering
【24h】

Cardiac extracellular matrix-fibrin hybrid scaffolds with tunable properties for cardiovascular tissue engineering

机译:具有可调节特性的心血管细胞外基质-纤维蛋白混合支架,用于心血管组织工程

获取原文
获取原文并翻译 | 示例
           

摘要

Solubilized cardiac extracellular matrix (ECM) is being developed as an injectable therapeutic that offers promise for promoting cardiac repair. However, the ECM alone forms a hydrogel that is very soft compared to the native myocardium. As both the stiffness and composition of the ECM are important in regulating cell behavior and can have complex synergistic effects, we sought to develop an ECM-based scaffold with tunable biochemical and mechanical properties. We used solubilized rat cardiac ECM from two developmental stages (neonatal, adult) combined with fibrin hydrogels that were cross-linked with transglutaminase. We show that ECM was retained within the gels and that the Young's modulus could be tuned to span the range of the developing and mature heart. C-kit+ cardiovascular progenitor cells from pediatric patients with congenital heart defects were seeded into the hybrid gels. Both the elastic modulus and composition of the scaffolds impacted the expression of endothelial and smooth muscle cell genes. Furthermore, we demonstrate that the hybrid gels are injectable, and thus have potential for minimally invasive therapies. ECM fibrin hybrid scaffolds offer new opportunities for exploiting the effects of both composition and mechanical properties in directing cell behavior for tissue engineering. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
机译:可溶性心脏细胞外基质(ECM)被开发为可注射的治疗剂,有望促进心脏修复。但是,单独的ECM形成的水凝胶与天然心肌相比非常柔软。由于ECM的刚度和组成对调节细胞行为很重要,并且可能具有复杂的协同作用,因此我们试图开发一种具有可调节的生化和机械特性的基于ECM的支架。我们使用了来自两个发育阶段(新生儿,成人)的增溶大鼠心脏ECM,并与通过转谷氨酰胺酶交联的纤维蛋白水凝胶结合使用。我们表明,ECM被保留在凝胶中,并且可以调整杨氏模量以涵盖发育中和成熟心脏的范围。将患有先天性心脏缺陷的小儿患者的C-kit +心血管祖细胞接种到杂交凝胶中。支架的弹性模量和组成都影响内皮和平滑肌细胞基因的表达。此外,我们证明了杂化凝胶是可注射的,因此具有微创疗法的潜力。 ECM纤维蛋白混合支架为组织工程中指导细胞行为的组合物和机械性能的影响提供了新的机会。 (C)2014 Acta Materialia Inc.,由Elsevier Ltd.发行。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号